Abstract
The insulin-like growth factor 1 (IGF-1) signaling pathway regulates critical biological processes including development, homeostasis, and aging. Dysregulation of this pathway has been implicated in a myriad of diseases such as cancers, neurodegenerative diseases, and metabolic disorders, making the IGF-1 signaling pathway a prime target to develop therapeutic and intervention strategies. Recently, small non-coding RNA molecules in ~22 nucleotide length, microRNAs (miRNAs), have emerged as a new regulator of biological processes in virtually all organ systems and increasing studies are linking altered miRNA function to disease mechanisms. A miRNA binds to 3'UTRs of multiple target genes and coordinately downregulates their expression, thereby exerting a profound influence on gene regulatory networks. Here we review the components of the IGF-1 signaling pathway that are known targets of miRNA regulation, and highlight recent studies that suggest therapeutic potential of these miRNAs against various diseases.
Original language | English (US) |
---|---|
Article number | 472 |
Journal | Frontiers in Genetics |
Volume | 5 |
Issue number | JAN |
DOIs | |
State | Published - 2015 |
Keywords
- Aging
- Aging-related disease
- IGF-1 signaling
- Micrornas
- Therapeutic agents
ASJC Scopus subject areas
- Molecular Medicine
- Genetics
- Genetics(clinical)